IR Information
IR Information
News Release
News release
-
2025.07.31
Notice Regarding the Conclusion of a Joint Research Agreement
-
2025.07.23
Announcement of Joint Research Agreement with Yamaguchi University
-
2025.07.23
Notice Regarding the Conclusion of a Joint Research Agreement
-
2025.06.25
Notice of Resolutions of the 23rd Ordinary General Meeting of Shareholders
-
2025.06.24
Report on participation in BioUSA 2025
Financial Information
Disclosure
Financial Results
23rd Fiscal Period (Results for March 2025) | |
---|---|
Net sales (Thousands of yen) | 61,438 |
Operating income (thousand yen) | 1,420,545 |
Net income (thousand yen) | 1,084,701 |
Net assets (Thousands of yen) | 5,257,192 |
Total assets (Thousands of yen) | 5,585,185 |
Equity ratio (%) | 94.1 |
Business Report
Business report
23rd Term
Business Overview
22nd Term
Business Overview
21th Term
Business Overview
20th Term
Business Overview
19th Term
Business Overview